Cell Signaling Technology, Inc.

06/17/2026

Still probing with just a single antibody on your western blot? 🕒 You’re likely spending more time and resources than you need to.

Multiplex fluorescent western blotting allows you to detect multiple proteins at once, compare phospho and total targets in the same lane, and generate more reproducible data with a broader dynamic range.

The latest walks through key advantages and practical tips to help you design better experiments.

Design multiplex fluorescent western blots with confidence. Improve quantification, dynamic range, and reproducibility with practical expert tips.

06/17/2026

Generate multiplex images that result in meaningful, actionable insights.

Join us at Visiopharm’s Research Rebellion Tour to learn how mIHC assays interrogate the spatial context of cell types and biomarkers within the TME—and how to:

✅ Amplify multiple targets in FFPE tissue
✅ Map critical spatial relationships
✅ Discover novel biomarkers for predicting therapeutic response

Register here: https://hubs.ly/Q04dL8W50

06/16/2026

When gene expression changes without mutations, epigenetic reprogramming may be at play 🧬

CST chromatin profiling kits and validated antibodies enable identification of genomic changes altering gene expression.

https://hubs.ly/Q04fl98K0

06/15/2026

Coming Soon: When you incorporate CST® GMP-grade CAR-T enrichment and detection reagents, you can:

✅ Experience smoother handoffs when the same GMP-grade reagents are used in pre-clinical development as in manufacturing and QC
✅ Save time and paperwork qualifying reagents for clinical environments

Learn more: https://hubs.ly/Q04jQKVK0

06/15/2026

Stop by our booth at Discovery & Development Europe 2026! 🧬
Learn how our assay-ready antibodies deliver the high specificity and performance you need for high-content imaging, high-throughput screening, Simple Western, and beyond.

Ensure your results are reproducible from the start.

See you there! https://hubs.ly/Q04jQH3-0

06/12/2026

🔬 Are your samples resistant to PARP inhibitors?

Use the new IHC-validated Rad51 (F4L4Y) Rabbit monoclonal antibody #84555 to visualize RAD51 foci and find out.

• More foci = functional homologous recombination repair (HRR).
• Fewer foci = dysfunctional HRR and potential PARP inhibitor resistance.

See the data & add Rad51 (F4L4Y) Rabbit mAb #84555 to your cart. https://hubs.ly/Q04g8qxw0

06/11/2026

Join Dr Christina Theisgen at to discover how stringent, application-specific antibody validation strategies eliminate background noise and boost image segmentation accuracy, ensuring your high-content assays deliver the reproducible data needed to accelerate target validation workflows. https://hubs.ly/Q04j0ms70

06/11/2026

In our recent article, CST Principal Scientist Alissa Nelson, PhD, shows how combining antibody-based assays with DIA LC‑MS and PTMScan® ubiquitin profiling can fully characterize an androgen receptor degrader—from on‑target activity to off‑target substrates and site‑level ubiquitination changes.

Read the blog to see how this integrated workflow can de‑risk your next TPD program 👇
https://hubs.ly/Q049BflR0

06/10/2026

Last chance to register for our webinar on June 11, 2026, 1:00–2:00 PM EDT.

Learn more about choosing the right antibody for imaging success and how CST validates each new antibody as a scientific project.

👉 Register now: https://hubs.ly/Q04j24YP0

06/09/2026

Get Your Simple Western Assays Up and Running Fast 🚀

Save valuable time with over 900 antibodies already validated and optimized on Simple Western systems.

Find out why more R&D Systems Simple Western assays use CST® antibodies than from any other supplier. Read the blog here: https://hubs.ly/Q04gpjZB0